Skip to main content
. 2017 Mar 15;2017(3):CD012600. doi: 10.1002/14651858.CD012600

Sepulveda 2007.

Clinical features and settings Routine screening
Participants 1287 participants
Chile ‐ fetal medicine centre
January 2003 ‐ January 2006
Pregnant women
Median maternal age 33 years (range 14‐47 years), 35.4% ≥ 35 years
Singleton pregnancies
11‐14 weeks' gestation
Study design Prospective cohort
Target condition and reference standard(s) Down's syndrome: 31 cases
Reference standards: CVS, amniocentesis, cordocentesis or follow‐up to birth
Index and comparator tests Maternal age
First trimester NT and nasal bone assessment (Accuvix XQ, Medison or Voluson 730, GE Healthcare) (only included in study if scanned by 1 of 2 fetal medicine specialists following FMF guidelines)
Follow‐up Cases of chromosomal abnormality were identified from the cytogenetics laboratory logbook, which recorded all the cytogenetic studies performed prenatally, after a spontaneous abortion or fetal death, or in neonates with physical abnormalities. Information from the remaining cases was obtained from the delivery records and neonatal discharge summaries, which recorded the condition of the neonate at birth and the physical examination performed by a neonatologist
Aim of study To report their experience with first trimester screening for trisomy 21 by using the combination of NT thickness and nasal bone assessment
Notes  
Table of Methodological Quality
Item Authors' judgement Description
Representative spectrum? 
 All tests Yes Routine screening of typical pregnant population
Acceptable reference standard? 
 All tests Yes Karyotyping or follow‐up to birth
Partial verification avoided? 
 All tests Unclear Unclear if all women received a reference standard
Differential verification avoided? 
 All tests No Choice of reference standard depended on index test results
Incorporation avoided? 
 All tests Yes Reference standard was independent of the index test
Reference standard results blinded? 
 All tests No Reference standard interpreted with knowledge of index test results
Index test results blinded? 
 All tests Yes Index test interpreted without knowledge of reference standard results
Relevant clinical information? 
 All tests Yes Information available as would be in standard clinical practice
Uninterpretable results reported? 
 All tests No No details given for test failures/uninterpretable measurements
Withdrawals explained? 
 All tests No No details of withdrawals given